Merck & Co Inc (NYSE:MRK, ETR:6MK) announced it is acquiring Eyebio, a privately held ophthalmology-focused biotech firm, in a deal valued up to $3 billion....

Related Keywords

Tony Adamis , David Guyer , Merck Research Laboratories , Merck Co Inc , Merck Research ,